ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Inhibition of the proliferation, invasion, migration, and epithelial-mesenchymal transition of prostate cancer cells through the action of ATP1A2 on the TGF-β/Smad pathway

Zhang, Bashan*; Zhu, Zinian; Zhang, Xibo; Li, Fei; Ding, Aijiao南方医科大学
Translational Andrology and Urology2022-1DOI: 10.21037/tau-21-1117
5被引7阅读
引用收藏
分享

摘要

Background: Prostate cancer (PC) is one of the major male malignancies worldwide. Because Na+-K+-ATPase is widely involved in various pathological processes, but the action of its alpha 2 subtype (ATP1A2) in PC is unclear, we investigated the role of ATP1A2 in the invasion and migration of PC cells. @@@ Methods: We measured the expression levels of ATP1A2 in human normal prostate epithelial cell line (RWPE-1) and PC cell lines (PC-3 and DU145) by quantitative real-time PCR (qRT-PCR) and western blot. Cell proliferation, apoptosis, migration, and invasion of PC-3 and DU145 cells were investigated through clone formation assay, EdU assay, flow cytometry and transwell assay, respectively. The effect of ATP1A2 on a tumor-inhibitory pathway [transforming growth factor-beta (TGF-beta)/Smad] was assessed using western blot. In addition, tumor formation was detected using in vivo xenograft model in male BALB/c nude mice. @@@ Results: The Cancer Genome Atlas (TCGA) analysis showed that ATP1A2 expression was reduced in PC patients (P<0.05), and patients with low ATP1A2 expression had a lower survival rate (P<0.05). ATP1A2 levels were significantly reduced in PC-3 and DU145 cells, compared with RWPE-1 cells (P<0.01). We also demonstrated that overexpression of ATP1A2 significantly inhibited the proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) of PC-3 and DU145 cells (P<0.01) and promoted apoptosis (P<0.01). However, silencing ATP1A2 had the opposite effect (P<0.01). In addition, overexpression of ATP1A2 significantly inhibited the TGF-beta/Smad pathway (P<0.01), whereas silencing ATP1A2 activated the TGF-beta/Smad pathway (P<0.01). Meanwhile, the effect of ATP1A2 silencing on the proliferation, apoptosis, migration and invasion was reversed by TGF-beta/Smad pathway inhibitor (LY364947). Furthermore, ATP1A2 inhibited tumor growth in vivo. @@@ Conclusions: ATP1A2 inhibited proliferation, apoptosis, migration, invasion, and EMT in PC by inhibiting the TGF-beta/Smad pathway.

学科与关键词

关键词
ATP1A2prostate cancer cell (PC cell)transforming growth factor-beta/Smad (TGF-beta/Smad)invasionmigration
相关
加载中…
  • SMARCC1 Suppresses Tumor Progression by Inhibiting the PI3K/AKT Signaling Pathway in Prostate Cancer
    Xiao, Zhao-Ming; Lv, Dao-Jun; Yu, Yu-Zhong; Wang, Chong; Xie, Tao; Wang, Tao; Song, Xian-Lu; Zhao, Shan-Chao*Frontiers in Cell and Developmental Biology, 2021, 9: 678967.被引 9
  • PRPF19 promotes the proliferation, migration, and inhibits autophagy in prostate cancer by suppressing SLC40A1
    Zhang, Guofei*; Zhang, Wansong; Dan, Mingjiang; Zou, Feng; Qiu, Chunming; Sun, CanbiaoChinese Journal of Physiology, 2023, 66(5): 379-387.
  • The ALDOA Metabolism Pathway as a Potential Target for Regulation of Prostate Cancer Proliferation
    Kuang, Qiwen; Liang, Yuxiang; Zhuo, Yangjia; Cai, Zhiduan; Jiang, Funeng; Xie, Jianjiang; Zheng, Yu; Zhong, Weide*OncoTargets and Therapy, 2021, 14: 3353-3366.被引 8
查看全部 →

发表信息

论文状态
公开发表
期刊
Translational Andrology and Urology
发表日期
2022-01
卷期
第 11 卷, 第 1 期
页码
53-66
DOI
10.21037/tau-21-1117
期刊等级
4区
成果收录
SCIE

作者

  • Z

    Zhang, Bashan (通讯) (第一作者)

    southern med univ

  • Z

    Zhu, Zinian

    southern med univ

查看全部 5 位作者收起作者
  • Z

    Zhang, Xibo

    southern med univ

  • L

    Li, Fei

    southern med univ

  • D

    Ding, Aijiao

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417